Abstract

Brazil is a country of low hepatitis B virus (HBV) endemicity in which the genotype A of HBV (HBV/A) is the most prevalent. The complete nucleotide sequences of 26 HBV/A isolates, originating from eight Brazilian states, were determined. All were adw2. Twenty-three belonged to subgenotype A1 and three to A2. By phylogenetic analysis, it was shown that all the 23 HBV/A1 isolates clustered together with isolates from Bangladesh, India, Japan, Nepal, the Philippines and United Arab Emirates, but not with those of Congo, Kenya, Malawi, Rwanda, South Africa, Tanzania, Uganda and Zimbabwe. Four amino acid residues in the polymerase (His138 in the terminal protein domain, Pro18 and His90 in the spacer, and Ser109 in the reverse transcriptase), and one (Phe17) in the precore region, predominated in Latin American and Asian HBV/A1 isolates, but were rarely encountered in African isolates, with the exception of those from Somalia. Specific variations of two adjacent amino acids in the C-terminal domain of the HBx protein, namely Ala146 and Pro147, were found in all the Brazilian, but rarely in the other HBV/A1 isolates. By Bayesian analysis, the existence of an ‘Asian-American’ clade within subgenotype A1 was supported by a posterior probability value of 0.996. The close relatedness of the Brazilian, Asian and Somalian isolates suggests that the HBV/A1 strains predominant in Brazil did not originate from the five million slaves who were imported from Central and Western Africa from 1551 to 1840, but rather from the 300–400,000 captives forcibly removed from southeast Africa at the middle of the 19th century.

Highlights

  • More than 240 million people are chronically infected with hepatitis B virus (HBV) [1]

  • HBV prevalence, measured by the presence of hepatitis B surface antigen (HBsAg) in the serum, varies from,1% to .10% depending on the geographic region, with the highest prevalence in sub-Saharan Africa and southeast Asia

  • All isolates had a genome size of 3,221 nucleotides

Read more

Summary

Introduction

More than 240 million people are chronically infected with hepatitis B virus (HBV) [1]. HBV prevalence, measured by the presence of hepatitis B surface antigen (HBsAg) in the serum, varies from ,1% to .10% depending on the geographic region, with the highest prevalence in sub-Saharan Africa and southeast Asia. Based on a genomic sequence divergence .7.5% over the entire DNA genome, HBV isolates have been classified into eight genotypes (HBV/A to H) [2]. Genotypes A–D and F are further divided into subgenotypes that show a sequence divergence of about 4% between them [2]. HBV genotypes and subgenotypes have distinct geographic distribution and may be responsible for differences in the natural history and clinical outcome of the infection [5,6,7,8]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call